Results 21 to 30 of about 10,710 (162)

Identification and Structural Characterization of Viroporins from Deadly Hemorrhagic Viruses [PDF]

Viruses
Crimean–Congo hemorrhagic fever virus (CCHF-V) and Ebola virus are lethal pathogens that cause widespread outbreaks of hemorrhagic fever. Both diseases can be transmitted through contact with the bodily fluids of infected individuals, but as an arbovirus,
Hiya Lahiri, Kingshuk Basu, Isaiah T. Arkin   +2 more
doaj   +2 more sources

Key features of Ebola hemorrhagic fever: a review

Asian Pacific Journal of Tropical Biomedicine, 2014
The current outbreak of Ebola virus in West Africa has become a devastating problem, with a mortality rate around 51%; over 3 132 deaths have been confirmed and even more are expected in this case.
Zulane Lima Sousa
exaly   +3 more sources

Ebola and Marburg Hemorrhagic Fevers: Neglected Tropical Diseases?

PLoS Neglected Tropical Diseases, 2012
Ebola hemorrhagic fever (EHF) and Marburg hemorrhagic fever (MHF) are rare viral diseases, endemic to central Africa. The overall burden of EHF and MHF is small in comparison to the more common protozoan, helminth, and bacterial diseases typically referred to as neglected tropical diseases (NTDs).
Pierre Rollin, Adam Macneil
exaly   +5 more sources

Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome [PDF]

Journal of Infectious Diseases, 2014
Anita Mcelroy, Christina Spiropoulou, Pierre Rollin   +2 more
exaly   +2 more sources

Repurposed Medicines for Viruses With Epidemic or Pandemic Potential: A Horizon Scan. [PDF]

Pharmacol Res Perspect
ABSTRACT Viruses such as Ebola, Marburg, influenza, mpox, MERS‐CoV, SARS‐CoV, and SARS‐CoV‐2 may be considered pathogens of epidemic or pandemic concern. Developing novel antiviral medicines can be time‐consuming and resource intensive. Repurposing existing medicines with known or potential antiviral activity offers a faster, cost‐effective strategy to
Akinbolade S, Potter R, Inskip A, Nesworthy J, Brock K, Norman G.   +5 more
europepmc   +2 more sources

The Hemorrhagic Fever: Ebola and Other Viruses

Pakistan Journal of Medicine and Dentistry
Presently, Ebola epidemic in West Africa emphasizes an immediate need to update management guidelines of viral hemorrhagic fever and develop new vaccines and treatments.
Faraz Ahmed Baig, Amna Hamid
doaj   +1 more source

Ebola Hemorrhagic Shock Syndrome-on-a-Chip

iScience, 2020
Summary: Ebola virus, for which we lack effective countermeasures, causes hemorrhagic fever in humans, with significant case fatality rates. Lack of experimental human models for Ebola hemorrhagic fever is a major obstacle that hinders the development of
Abidemi Junaid, Huaqi Tang, Anne van Reeuwijk, Yasmine Abouleila, Petra Wuelfroth, Vincent van Duinen, Wendy Stam, Anton Jan van Zonneveld, Thomas Hankemeier, Alireza Mashaghi   +9 more
doaj   +1 more source

A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever [PDF]

Journal of Infectious Diseases, 2013
Heinz Feldmann, Hideki Ebihara, Marko Zivcec   +2 more
exaly   +2 more sources

Emergence of deadly viral haemorrhagic fever disease outbreaks in West Africa

Virulence, 2023
Recent viral hemorrhagic fever (VHF) disease outbreaks caused by Ebola virus (EBOV) and Marburg virus (MARV) in West Africa are unique and alarming.
Widaliz Vega-Rodriguez, Hinh Ly
doaj   +1 more source

Ebolavirosis: a 2014 Review for Clinicians

Acta Médica Portuguesa, 2014
Ebolavirosis, like Marburgvirosis, are African zoonosis, and for both the primary animal reservoir are bats. It is a typical acute haemorrhagic fever, characterized by a high lethality rate.
Jaime Nina
doaj   +1 more source